Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Colorectal Neoplasms | 17 | 2022 | 6961 | 0.980 |
Why?
|
Colonic Neoplasms | 9 | 2021 | 2532 | 0.860 |
Why?
|
DNA Glycosylases | 2 | 2022 | 125 | 0.840 |
Why?
|
Esophageal Neoplasms | 4 | 2023 | 1659 | 0.690 |
Why?
|
Adenoma | 6 | 2020 | 2155 | 0.510 |
Why?
|
Aspirin | 4 | 2022 | 3135 | 0.430 |
Why?
|
Adenomatous Polyps | 1 | 2014 | 109 | 0.420 |
Why?
|
Adenocarcinoma | 3 | 2023 | 6363 | 0.370 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1379 | 0.350 |
Why?
|
Receptors, CXCR4 | 1 | 2015 | 729 | 0.340 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2020 | 2271 | 0.320 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 249 | 0.310 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2015 | 2054 | 0.300 |
Why?
|
Barrett Esophagus | 2 | 2023 | 494 | 0.290 |
Why?
|
Genetic Predisposition to Disease | 12 | 2023 | 18076 | 0.290 |
Why?
|
Precancerous Conditions | 1 | 2014 | 975 | 0.270 |
Why?
|
Genome-Wide Association Study | 12 | 2022 | 12803 | 0.260 |
Why?
|
Germ-Line Mutation | 1 | 2014 | 1885 | 0.240 |
Why?
|
Microsatellite Instability | 2 | 2020 | 726 | 0.220 |
Why?
|
ras Proteins | 3 | 2014 | 1054 | 0.220 |
Why?
|
Molecular Targeted Therapy | 1 | 2014 | 2824 | 0.210 |
Why?
|
Peptides | 1 | 2015 | 4338 | 0.210 |
Why?
|
Sulindac | 1 | 2002 | 29 | 0.200 |
Why?
|
Genomics | 4 | 2022 | 5926 | 0.190 |
Why?
|
Rectal Neoplasms | 2 | 2021 | 1183 | 0.180 |
Why?
|
Adenomatous Polyposis Coli | 2 | 2014 | 219 | 0.180 |
Why?
|
Carcinoma, Verrucous | 1 | 2020 | 26 | 0.180 |
Why?
|
Antineoplastic Agents | 2 | 2020 | 13635 | 0.180 |
Why?
|
Microsatellite Repeats | 2 | 2020 | 784 | 0.170 |
Why?
|
DNA Polymerase II | 1 | 2020 | 103 | 0.160 |
Why?
|
Genetic Variation | 4 | 2020 | 6612 | 0.160 |
Why?
|
Interferon Regulatory Factor-3 | 1 | 2020 | 145 | 0.160 |
Why?
|
Gap Junctions | 1 | 2020 | 230 | 0.150 |
Why?
|
Polymorphism, Single Nucleotide | 10 | 2021 | 16040 | 0.150 |
Why?
|
Genetic Loci | 2 | 2019 | 2630 | 0.150 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2020 | 157 | 0.150 |
Why?
|
Polyps | 1 | 2020 | 200 | 0.150 |
Why?
|
Nucleotidyltransferases | 1 | 2020 | 243 | 0.150 |
Why?
|
Dinoprostone | 1 | 2020 | 593 | 0.140 |
Why?
|
Genetic Heterogeneity | 1 | 2021 | 735 | 0.140 |
Why?
|
DNA Mismatch Repair | 1 | 2020 | 432 | 0.140 |
Why?
|
Proto-Oncogene Proteins | 3 | 2014 | 4521 | 0.130 |
Why?
|
Drug Tolerance | 1 | 2018 | 365 | 0.130 |
Why?
|
Colon | 2 | 2021 | 1797 | 0.130 |
Why?
|
Anticarcinogenic Agents | 1 | 2017 | 250 | 0.120 |
Why?
|
BRCA2 Protein | 1 | 2020 | 802 | 0.120 |
Why?
|
Retinoblastoma-Like Protein p107 | 1 | 2014 | 70 | 0.110 |
Why?
|
Crohn Disease | 2 | 2018 | 2281 | 0.110 |
Why?
|
Adrenomedullin | 1 | 2013 | 85 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Common Bile Duct Neoplasms | 1 | 2014 | 121 | 0.110 |
Why?
|
Case-Control Studies | 8 | 2021 | 22228 | 0.110 |
Why?
|
DNA Helicases | 2 | 2020 | 852 | 0.110 |
Why?
|
BRCA1 Protein | 1 | 2020 | 1155 | 0.110 |
Why?
|
Ampulla of Vater | 1 | 2014 | 150 | 0.110 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2020 | 1245 | 0.110 |
Why?
|
Gastrointestinal Agents | 1 | 2018 | 511 | 0.100 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 313 | 0.100 |
Why?
|
Strongyloides stercoralis | 1 | 2012 | 23 | 0.100 |
Why?
|
Strongyloidiasis | 1 | 2012 | 27 | 0.100 |
Why?
|
Codon, Nonsense | 1 | 2014 | 288 | 0.100 |
Why?
|
HTLV-I Infections | 1 | 2012 | 103 | 0.100 |
Why?
|
Humans | 38 | 2023 | 766117 | 0.100 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2002 | 2838 | 0.100 |
Why?
|
Bone Morphogenetic Protein 4 | 1 | 2012 | 163 | 0.090 |
Why?
|
DNA Mutational Analysis | 1 | 2020 | 4112 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 3 | 2014 | 1765 | 0.090 |
Why?
|
Prospective Studies | 7 | 2022 | 54812 | 0.090 |
Why?
|
Endoscopy, Digestive System | 1 | 2014 | 358 | 0.090 |
Why?
|
Peutz-Jeghers Syndrome | 1 | 2011 | 61 | 0.090 |
Why?
|
Jejunum | 1 | 2012 | 474 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 941 | 0.090 |
Why?
|
Male | 21 | 2023 | 363935 | 0.080 |
Why?
|
DNA Repair | 1 | 2019 | 2048 | 0.080 |
Why?
|
Oncogene Proteins | 1 | 2014 | 711 | 0.080 |
Why?
|
Aged | 15 | 2022 | 171219 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2018 | 2879 | 0.080 |
Why?
|
Neoplasms | 2 | 2016 | 22344 | 0.080 |
Why?
|
Medical Informatics | 1 | 2016 | 743 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12235 | 0.080 |
Why?
|
Disease Progression | 4 | 2023 | 13616 | 0.080 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1150 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1805 | 0.070 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2744 | 0.070 |
Why?
|
Databases, Genetic | 1 | 2015 | 1756 | 0.070 |
Why?
|
Female | 20 | 2023 | 396233 | 0.070 |
Why?
|
Models, Genetic | 1 | 2018 | 3448 | 0.070 |
Why?
|
Gene Expression Regulation, Neoplastic | 4 | 2020 | 8612 | 0.070 |
Why?
|
Genotype | 5 | 2021 | 13028 | 0.070 |
Why?
|
Genetic Markers | 1 | 2014 | 2603 | 0.070 |
Why?
|
Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2011 | 388 | 0.070 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3112 | 0.070 |
Why?
|
Mutation | 2 | 2022 | 30209 | 0.070 |
Why?
|
Middle Aged | 17 | 2022 | 223083 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4342 | 0.070 |
Why?
|
Natural Language Processing | 1 | 2015 | 1198 | 0.060 |
Why?
|
Software | 2 | 2018 | 4463 | 0.060 |
Why?
|
Carcinoma | 1 | 2017 | 2313 | 0.060 |
Why?
|
Odds Ratio | 4 | 2020 | 9657 | 0.060 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2020 | 5336 | 0.060 |
Why?
|
Workflow | 2 | 2022 | 859 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1897 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2898 | 0.050 |
Why?
|
Colitis, Ulcerative | 1 | 2015 | 1912 | 0.050 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4780 | 0.050 |
Why?
|
Adult | 12 | 2023 | 223139 | 0.050 |
Why?
|
Interleukin-8 | 1 | 2005 | 699 | 0.050 |
Why?
|
Genes, src | 1 | 2002 | 51 | 0.050 |
Why?
|
Septins | 1 | 2022 | 47 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2014 | 3594 | 0.050 |
Why?
|
Aged, 80 and over | 7 | 2021 | 59515 | 0.050 |
Why?
|
Colon, Descending | 1 | 2021 | 6 | 0.050 |
Why?
|
Colon, Ascending | 1 | 2021 | 14 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2023 | 2946 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9601 | 0.050 |
Why?
|
Colon, Transverse | 1 | 2021 | 25 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2023 | 11094 | 0.050 |
Why?
|
Risk Factors | 7 | 2023 | 74857 | 0.040 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39243 | 0.040 |
Why?
|
Colon, Sigmoid | 1 | 2021 | 124 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2006 | 998 | 0.040 |
Why?
|
Cecum | 1 | 2021 | 231 | 0.040 |
Why?
|
3T3 Cells | 1 | 2002 | 1079 | 0.040 |
Why?
|
Biopsy | 2 | 2023 | 6768 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1142 | 0.040 |
Why?
|
Young Adult | 7 | 2021 | 59868 | 0.040 |
Why?
|
Signal Transduction | 3 | 2020 | 23605 | 0.040 |
Why?
|
Genes, ras | 1 | 2002 | 656 | 0.040 |
Why?
|
Risk Assessment | 4 | 2023 | 24276 | 0.040 |
Why?
|
Esophagoscopy | 1 | 2020 | 398 | 0.040 |
Why?
|
DNA Modification Methylases | 1 | 2019 | 207 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5367 | 0.040 |
Why?
|
Numerical Analysis, Computer-Assisted | 1 | 2018 | 120 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2006 | 3501 | 0.040 |
Why?
|
Alleles | 2 | 2021 | 6892 | 0.040 |
Why?
|
DNA Repair Enzymes | 1 | 2019 | 342 | 0.040 |
Why?
|
Early Detection of Cancer | 2 | 2022 | 3238 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2877 | 0.030 |
Why?
|
Genes, Neoplasm | 1 | 2018 | 369 | 0.030 |
Why?
|
Prostaglandins | 1 | 2017 | 396 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 367 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9378 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2016 | 399 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2016 | 378 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2627 | 0.030 |
Why?
|
Computational Biology | 2 | 2018 | 3565 | 0.030 |
Why?
|
Age Distribution | 1 | 2021 | 2865 | 0.030 |
Why?
|
Animals | 6 | 2020 | 168800 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12426 | 0.030 |
Why?
|
Rectum | 1 | 2019 | 896 | 0.030 |
Why?
|
Algorithms | 1 | 2015 | 14066 | 0.030 |
Why?
|
Cell Division | 1 | 2002 | 4466 | 0.030 |
Why?
|
Kinetics | 1 | 2002 | 6273 | 0.030 |
Why?
|
Transfection | 1 | 2002 | 5739 | 0.030 |
Why?
|
Risk | 2 | 2016 | 9599 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3344 | 0.030 |
Why?
|
Mice, Nude | 2 | 2013 | 3610 | 0.030 |
Why?
|
Prognosis | 3 | 2020 | 29912 | 0.030 |
Why?
|
Transcription Factors | 2 | 2020 | 12130 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 2014 | 114 | 0.030 |
Why?
|
Tumor Microenvironment | 2 | 2018 | 3942 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1246 | 0.030 |
Why?
|
Chromones | 1 | 2012 | 148 | 0.020 |
Why?
|
Remission Induction | 1 | 2018 | 2413 | 0.020 |
Why?
|
Human T-lymphotropic virus 1 | 1 | 2012 | 143 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8347 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2016 | 1996 | 0.020 |
Why?
|
Telomerase | 1 | 2016 | 749 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2020 | 2590 | 0.020 |
Why?
|
Cell Hypoxia | 1 | 2013 | 656 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2017 | 1437 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6324 | 0.020 |
Why?
|
Reimbursement Mechanisms | 1 | 2016 | 669 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2012 | 489 | 0.020 |
Why?
|
Cell Line, Tumor | 3 | 2013 | 17071 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2002 | 10737 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2795 | 0.020 |
Why?
|
Radiography, Abdominal | 1 | 2012 | 543 | 0.020 |
Why?
|
Morpholines | 1 | 2012 | 584 | 0.020 |
Why?
|
Flavonoids | 1 | 2012 | 446 | 0.020 |
Why?
|
Colectomy | 1 | 2014 | 697 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8525 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3623 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2017 | 1890 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2016 | 4617 | 0.020 |
Why?
|
Promoter Regions, Genetic | 2 | 2012 | 5784 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10087 | 0.020 |
Why?
|
Research | 1 | 2016 | 1975 | 0.020 |
Why?
|
Pelvis | 1 | 2012 | 737 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1893 | 0.020 |
Why?
|
Primary Health Care | 1 | 2023 | 4736 | 0.020 |
Why?
|
Cholesterol | 1 | 2016 | 2902 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2018 | 3140 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 10380 | 0.020 |
Why?
|
Mice | 3 | 2020 | 81839 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5791 | 0.020 |
Why?
|
Abdominal Pain | 1 | 2012 | 1069 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3604 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3796 | 0.020 |
Why?
|
Cohort Studies | 2 | 2020 | 41684 | 0.010 |
Why?
|
Adolescent | 3 | 2020 | 88819 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14456 | 0.010 |
Why?
|
Down-Regulation | 1 | 2012 | 2927 | 0.010 |
Why?
|
Computer Simulation | 1 | 2018 | 6254 | 0.010 |
Why?
|
Liver | 1 | 2020 | 7559 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2020 | 15403 | 0.010 |
Why?
|
rho-Associated Kinases | 1 | 2006 | 291 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9508 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9335 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3665 | 0.010 |
Why?
|
Referral and Consultation | 1 | 2016 | 3617 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2020 | 65219 | 0.010 |
Why?
|
Hydrogen Peroxide | 1 | 2005 | 740 | 0.010 |
Why?
|
Cytokines | 1 | 2017 | 7426 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2005 | 620 | 0.010 |
Why?
|
Enzyme Inhibitors | 1 | 2012 | 3722 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13273 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6206 | 0.010 |
Why?
|
Weight Loss | 1 | 2012 | 2711 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11035 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 81565 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7600 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16716 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2012 | 12976 | 0.010 |
Why?
|
Up-Regulation | 1 | 2005 | 4133 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10433 | 0.010 |
Why?
|
Time Factors | 1 | 2017 | 40108 | 0.010 |
Why?
|
Base Sequence | 1 | 2006 | 12405 | 0.010 |
Why?
|
Oxygen | 1 | 2005 | 4247 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2006 | 17597 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2014 | 15808 | 0.010 |
Why?
|
United States | 1 | 2019 | 72920 | 0.010 |
Why?
|
Models, Biological | 1 | 2006 | 9445 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20700 | 0.000 |
Why?
|